Immunogenicity and Safety of Havrix™ Co-Administered With a Diphtheria, Tetanus and Pertussis and a Haemophilus b Vaccine in Children Aged 15 Months
Clinical trial NCT00197236 · COMPLETED
Trial details
- NCT number
- NCT00197236
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-11-11
- Primary completion
- 2007-12-03
- Enrollment
- 468
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.